Overview
Neuroendocrine prostate cancer is rare, often resistant to hormone therapy.
Symptoms
- •Bone pain
- •Weight loss
- •Urinary symptoms
Diagnosis
- ✓Biopsy
- ✓Chromogranin A
- ✓Low PSA
Treatments
- →Chemotherapy
- →Somatostatin analogs
- →Radiation
Risk Factors
⚠️Prior ADT
Key Facts
- ℹ️Often develops after hormone therapy
- ℹ️Poor prognosis
ICD-10: C61 | Prevalence: nadir
Last updated: 11/9/2025